Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn’s disease: a cross-sectional study

Fig. 1

Boxplot of erythrocyte MTX-PGn concentrations in nmol/L for CD patients using oral (orange) versus subcutaneous (green) MTX. Median MTX-PG concentrations (range) for all patients were as follows: MTX-PG1 26.7 (9.9–170.1), MTX-PG2 17.4 (7.5–24.8), MTX-PG3 43.1 (15.3–96.1), MTX-PG4 19.7 (2.4–60.1), MTX-PG5 9.4 (1.1–24.1), MTX-PGtotal 117.1 (46.4–258.7) nmol/L

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us